International Journal of Clinical Case Reports 2024, Vol.14, No.3, 117-129 http://medscipublisher.com/index.php/ijccr 129 Wang Y., Zhang Y., Wu H., Huang L., Yu H., Xie Z., Zhang H., Zhang W., Chen X., Zhang H., Zhang H., Jia C., Xia S., and Wang S., 2021, Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: a randomized, double-blind, active-controlled phase 1 clinical trial., Vaccine, 39(29): 3871-3878. https://doi.org/10.1016/j.vaccine.2021.05.070 PMid:34088505 Watanabe A., Kani R., Iwagami M., Takagi H., Yasuhara J., and Kuno T., 2023, Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis., JAMA pediatrics, 177(4): 384-394. https://doi.org/10.1001/jamapediatrics.2022.6243 PMid:36689319 PMCid:PMC9871947 Wu Z., Hu Y., Xu M., Chen Z., Yang W., Jiang Z., Li M., Jin H., Cui G., Chen P., Wang L., Zhao G., Ding Y., Zhao Y., and Yin W., 2021, Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial, The Lancet, Infectious Diseases, 21: 803-812. https://doi.org/10.1016/S1473-3099(20)30987-7 PMid:33548194 Xia S., Zhang Y., Wang Y., Wang H., Yang Y., Gao G., Tan W., Wu G., Xu M., Lou Z., Huang W., Xu W., Huang B., Wang H., Wang W., Zhang W., Li N., Xie Z., Ding L., You W., Zhao Y., Yang X., Liu Y., Wang Q., Huang L., Yang Y., Xu G., Luo B., Wang W., Liu P., Guo W., and Yang X., 2020, Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial, The Lancet, Infectious Diseases, 21: 39-51. https://doi.org/10.1016/S1473-3099(20)30831-8 PMid:33069281 Xu S., Yang K., Li R., and Zhang L., 2020, mRNA vaccine era-mechanisms, drug platform and clinical prospection, International Journal of Molecular Sciences, 21(18): 6582. https://doi.org/10.3390/ijms21186582 PMid:32916818 PMCid:PMC7554980 Yang L., Tang L., Zhang M., and Liu C., 2022, Recent advances in the molecular design and delivery technology of mRNA for vaccination against infectious diseases, Frontiers in Immunology, 13: 896958. https://doi.org/10.3389/fimmu.2022.896958 PMid:35928814 PMCid:PMC9345514 Zhang C., Maruggi G., Shan H., and Li J., 2019, Advances in mRNA vaccines for infectious diseases, Frontiers in Immunology, 10: 594. https://doi.org/10.3389/fimmu.2019.00594 PMid:30972078 PMCid:PMC6446947 Zhang C., 2023, Revolutionizing vaccinology: the rise of mRNA vaccine, Theoretical and Natural Science, 21: 103-108. https://doi.org/10.54254/2753-8818/21/20230839
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==